Wells Fargo & Company Lantern Pharma Inc. Transaction History

Wells Fargo & Company

  • $410 Billion
  • Q1 2024

A detailed history of Wells Fargo & Company transactions in Lantern Pharma Inc. stock. As of the latest transaction made, Wells Fargo & Company holds 7,616 shares of LTRN stock, worth $35,109. This represents 0.0% of its overall portfolio holdings.

Number of Shares
7,616
Previous 4,495 69.43%
Holding current value
$35,109
Previous $19,000 252.63%
% of portfolio
0.0%
Previous 0.0%

Shares

15 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

May 10, 2024
BUY
$3.73 - $10.65 $11,641 - $33,238
3,121 Added 69.43%
7,616 $67,000
Q4 2023

Feb 09, 2024
BUY
$2.48 - $4.39 $7 - $13
3 Added 0.07%
4,495 $19,000
Q3 2023

Nov 13, 2023
BUY
$3.41 - $5.51 $13 - $22
4 Added 0.09%
4,492 $15,000
Q2 2023

Aug 15, 2023
BUY
$4.56 - $6.02 $9 - $12
2 Added 0.04%
4,488 $25,000
Q1 2023

May 12, 2023
BUY
$4.3 - $6.2 $2,154 - $3,106
501 Added 12.57%
4,486 $21,000
Q4 2022

Feb 13, 2023
BUY
$4.29 - $6.04 $4 - $6
1 Added 0.03%
3,985 $24,000
Q3 2022

Nov 14, 2022
BUY
$4.74 - $6.5 $966 - $1,326
204 Added 5.4%
3,984 $19,000
Q2 2022

Aug 12, 2022
BUY
$4.82 - $7.45 $1,070 - $1,653
222 Added 6.24%
3,780 $21,000
Q1 2022

May 16, 2022
BUY
$5.6 - $8.22 $13,025 - $19,119
2,326 Added 188.8%
3,558 $25,000
Q4 2021

Feb 14, 2022
BUY
$7.11 - $11.04 $1,983 - $3,080
279 Added 29.28%
1,232 $9,000
Q3 2021

Nov 15, 2021
SELL
$10.53 - $14.93 $68,129 - $96,597
-6,470 Reduced 87.16%
953 $11,000
Q2 2021

Aug 16, 2021
BUY
$12.94 - $19.89 $48,913 - $75,184
3,780 Added 103.76%
7,423 $109,000
Q1 2021

May 13, 2021
BUY
$14.34 - $21.92 $51,265 - $78,364
3,575 Added 5257.35%
3,643 $66,000
Q4 2020

Feb 09, 2021
BUY
$15.1 - $20.69 $860 - $1,179
57 Added 518.18%
68 $1,000
Q3 2020

Nov 05, 2020
BUY
$10.7 - $21.25 $117 - $233
11 New
11 $0

Others Institutions Holding LTRN

# of Institutions
38
Shares Held
1.06M
Call Options Held
124K
Put Options Held
22.2K
View Full List

About Lantern Pharma Inc.

LTRN Quotes by TradingView
  • Ticker LTRN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 10,830,900
  • Market Cap $49.9M
  • Description
  • Lantern Pharma Inc., a clinical stage biotechnology company, focuses on artificial intelligence, machine learning, and genomic data to streamline the drug development process. Its advanced drug candidate is LP-100, which is in phase II clinical trials to treat metastatic, castration-resistant, and prostate cancer. The company also develops LP-30...
More about LTRN
Track This Portfolio

Track Wells Fargo & Company Portfolio

Follow Wells Fargo & Company and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Wells Fargo & Company, based on Form 13F filings with the SEC.

News

Stay updated on Wells Fargo & Company with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email